Evidence-Based Complementary and Alternative Medicine / 2022 / Article / Tab 4 / Research Article
[Retracted] Effect of Thymosin on Inflammatory Factor Levels, Immune Function, and Quality of Life in Lung Cancer Patients Undergoing Radical Thoracoscopic Surgery Table 4 Comparison of immune function (
). Study group (n = 60) Control group (n = 60) t CD4 (+ %) Before 37.25 ± 9.26 35.37 ± 9.24 1.113 0.268 After 34.19 ± 7.29 30.58 ± 7.86 2.608 0.010 CD8 (+ %) Before 31.74 ± 9.57 31.21 ± 7.92 0.331 0.742 After 28.58 ± 7.26 25.08 ± 7.95 2.518 0.013 CD4+ /CD8+ Before 1.21 ± 0.29 1.17 ± 0.27 0.782 0.436 After 1.11 ± 0.32 0.86 ± 0.21 5.059 <0.001 NK (%) Before 24.52 ± 4.41 23.98 ± 4.08 0.696 0.488 After 21.75 ± 4.18 18.12 ± 3.82 4.966 <0.001
compared with pretreatment.